中财网 中财网股票行情
泽璟制药-U(688266)财务分析指标    年份：
截止日期2025-09-302025-06-302025-03-312024-12-312024-09-30
营业总收入(万元)59344.0137565.0316764.2053295.4438411.72
营业收入(万元)59344.0137565.0316764.2053295.4438411.72
营业总成本(万元)72548.6147516.8322489.1773065.6951277.83
营业成本(万元)5694.583882.091946.783699.142702.45
净利润(万元)-9395.40-7322.03-2812.33-14635.54-7373.43
归属于母公司的净利润(万元)-9341.62-7280.35-2826.22-13783.08-9790.30
营业利润(万元)-9676.26-7673.12-3001.70-15504.32-11254.81
利润总额(万元)-9831.96-7741.50-3031.70-15504.78-11260.27
少数股东损益(万元)-218.06-276.64-105.11-1246.75-1174.36
基本每股收益(元)-0.35(元)-0.28(元)-0.11(元)-0.52(元)-0.37(元)
稀释每股收益(元)-0.35(元)-0.28(元)-0.11(元)-0.52(元)-0.37(元)
非经常性损益(万元)2726.28--2181.873332.95665.38
扣除非经常性损益后净利润(万元)-12067.90-10264.14-5008.10-17116.03-10455.68
总资产(万元)301337.74299920.34291782.39300461.43296714.79
总负债(万元)186436.36182258.79169409.40175201.37166434.19
归属于母公司股东权益合计(万元)114901.39117661.54122601.30125385.79130338.75
股东权益合计(万元)114901.39117661.54122372.99125260.05130280.60
实收资本(股本)(万元)26470.8226470.8226470.8226470.8226470.82
资本公积(万元)310947.65311634.44312064.51312036.66309727.51
未分配利润(万元)-221015.87-218954.60-214500.47-211674.25-207681.47
经营活动产生的现金流量净额(万元)-1673.39-1702.03-625.323820.456664.71
经营活动现金流入小计(万元)76614.1647514.3221678.1487282.9070286.40
经营活动现金流出小计(万元)78287.5549216.3522303.4683462.4563621.70
投资活动产生的现金流量净额(万元)-6655.37-6234.26-2663.07-184510.14845.53
投资活动现金流入小计(万元)6594.351737.32717.74121708.86101686.58
投资活动现金流出小计(万元)13249.727971.583380.81306219.00100841.06
筹资活动产生的现金流量净额(万元)-68.502591.28-3179.61-5131.64-7812.56
筹资活动现金流入小计(万元)61602.1143152.1114132.19128861.8579800.00
筹资活动现金流出小计(万元)61670.6140560.8317311.80133993.4987612.56
期末现金及现金等价物余额(万元)13276.5316336.1815257.6321726.55207421.72
最后修改日期2025-11-012025-08-222025-04-212025-04-212024-10-29
↑返回页顶↑

转至泽璟制药-U（688266）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。